ADP-ribosylation of cyclophilin A by Pseudomonas aeruginosa exoenzyme S.

DiNovo AA, Schey KL, Vachon WS, McGuffie EM, Olson JC, Vincent TS
Biochemistry. 2006 45 (14): 4664-73

PMID: 16584201 · DOI:10.1021/bi0513554

The virulence of the opportunistic pathogen Pseudomonas aeruginosa (Pa) is in part mediated by the type III secretion (TTS) of bacterial proteins into eukaryotic hosts. Exoenzyme S (ExoS) is a bifunctional Pa TTS effector protein, with GTPase-activating (GAP) and ADP-ribosyltransferase (ADPRT) activities. Known cellular substrates of TTS-translocated ExoS (TTS-ExoS) ADPRT activity include proteins in the Ras superfamily and ERM family proteins. This study describes the ADP-ribosylation of a non-G-protein substrate of TTS-ExoS, cyclophilin A (CpA), a peptidyl-prolyl isomerase (PPIase). Four novel 17 kDa proteins (pI 6.5-6.8) were recognized in a proteomic screen of lysates of human epithelial cells that had been exposed to ExoS-producing Pa, but not an isogenic non-ExoS producing strain. The proteins were identified as isoforms of CpA using MALDI-TOF mass spectrometry and confirmed by Western blotting. Mutagenesis analysis identified arginine 55 and 69 of CpA as sites of ExoS ADP-ribosylation. Examination of the effect of ExoS ADP-ribosylation on CpA function found a moderate (19%) decrease in prolyl isomerization of a Xaa-Pro containing peptides. In comparison, GST-CpA co-immunoprecipitation studies found ExoS ADP-ribosylation of CpA to efficiently inhibit CpA binding to calcineurin/PP2B phosphatase. Our results support that ExoS ADP-ribosylates and affects the function of the cytosolic protein, CpA, with the predominant functional effect relating to interference of CpA-cellular protein interactions.

MeSH Terms (10)

Adenosine Diphosphate Ribose ADP Ribose Transferases Amino Acid Sequence Bacterial Toxins Cell Line, Tumor Cyclophilin A Humans Peptide Fragments Pseudomonas aeruginosa Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Connections (1)

This publication is referenced by other Labnodes entities: